Certain peptides are studied for their effects on sleep depth, sleep onset, and overnight recovery. Some work by supporting natural growth-hormone rhythms, others by acting on sleep-regulating pathways.
5 peptides commonly researched for this goal. Tap any card for the full guide.
Widely considered the gentlest GH-releasing peptide in its class. Commonly paired with CJC-1295 in research stacks.
Read the guideThe most 'clinically legitimate' GH secretagogue on this list. Formerly FDA-approved, now prescribed off-label at anti-aging clinics.
Read the guideTechnically not a peptide, but it belongs in this catalog because it's almost always discussed in the same breath. An oral GH secretagogue with real blood-sugar tradeoffs.
Read the guideOne of the few 'longevity peptides' with actual elderly-cohort human trial data behind it. From a specific, not-widely-replicated Russian research program.
Read the guideA sleep peptide with a compelling name but a surprisingly thin, decades-old evidence base. One to be upfront about.
Read the guideSleep peptides fall into two loose groups, and they work in very different ways. The first group are growth-hormone secretagogues like Ipamorelin, Sermorelin, and MK-677 (Ibutamoren). These do not sedate you. Instead, they nudge your body's natural growth-hormone rhythm, and most GH release happens during deep, slow-wave sleep. The research idea is that supporting that rhythm may deepen the slow-wave stage rather than just help you fall asleep faster. Worth noting: MK-677 is not technically a peptide, but it is almost always discussed alongside these compounds.
The second group acts more directly on sleep-regulating pathways. DSIP (Delta Sleep-Inducing Peptide) is the clearest example, named for the delta waves of deep sleep. Epithalon sits somewhere in between, studied mostly as a longevity peptide but with reported effects on sleep and circadian regulation in older adults. Be honest with yourself about the evidence here. Some of these compounds have extensive research behind them, and some, DSIP in particular, rest on a thin, decades-old base. Most of the sleep-specific claims come from small or animal studies, not large human trials.
| Peptide | Category | Studied for | Evidence |
|---|---|---|---|
| IpamorelinGH releasing peptide (GHRP) | Growth Hormone Secretagogues | Muscle Growth, Longevity | Extensive research |
| SermorelinGHRH analog | Growth Hormone Secretagogues | Muscle Growth, Longevity | Extensive research |
| MK-677 (Ibutamoren)Non-peptide GH secretagogue | Growth Hormone Secretagogues | Muscle Growth, Longevity | Extensive research |
| EpithalonEpitalon | Longevity & Cellular Health | Longevity, Sleep | Moderate research |
| DSIP (Delta Sleep-Inducing Peptide)Sleep peptide | Sleep & Stress | Sleep, Cognitive Function | Limited research |
If deep, slow-wave sleep is the goal, the growth-hormone secretagogues get the most attention. Ipamorelin is widely considered the gentlest GH-releasing peptide in its class, which is why it shows up so often in research stacks, frequently paired with CJC-1295. Sermorelin is the most clinically legitimate of the group. It was formerly FDA-approved and is now prescribed off-label at anti-aging clinics. Both are tied to the GH-during-deep-sleep mechanism rather than a sedative effect.
MK-677 is the oral option and raises GH over a longer window, but it carries real blood-sugar tradeoffs and can cause water retention and increased appetite. DSIP is the only compound here built around sleep induction itself, though its evidence is limited. Epithalon is the outlier: its human data comes from a specific, not-widely-replicated Russian research program in elderly cohorts, and sleep is a secondary finding, not the main event.
None of these are approved sleep medications, and none of them replace the basics. A consistent schedule, a dark room, and limited late caffeine do more for most people than any compound. Peptides are research chemicals, and the sleep evidence ranges from extensive on the GH-secretagogue side to genuinely limited for DSIP.
The tradeoffs are specific. GH secretagogues can affect blood sugar and fluid balance, MK-677 most notably. Epithalon's human evidence rests on a narrow research program. Purity and dosing vary widely in the research-chemical market. This page is educational, not medical advice. Talk to a qualified clinician before acting on any of it, especially if you take other medications or have a metabolic condition.
There is no single best answer, because the compounds work differently. Ipamorelin and Sermorelin are the most-researched and target deep, slow-wave sleep through growth-hormone rhythms. DSIP is the one built specifically around sleep induction, but its evidence base is thin and dated. The right comparison depends on whether you care about sleep depth or sleep onset.
They are research compounds, not approved sleep aids, so safety is not fully established. GH secretagogues like MK-677 carry real tradeoffs, including effects on blood sugar, appetite, and water retention. DSIP and Epithalon have limited long-term human safety data. Purity varies in the research market. Talk to a qualified clinician before considering any of them, particularly alongside other medications.
DSIP has a compelling name and was studied for sleep decades ago, but the evidence is surprisingly thin and has not been strongly replicated. Some early research suggested effects on sleep regulation and stress, yet results were inconsistent and mostly from small or older studies. It is one to be upfront about. The name promises more than the data currently delivers.
Most natural growth-hormone release happens during deep, slow-wave sleep. Peptides like Ipamorelin and Sermorelin are studied for supporting that GH rhythm, and the research idea is that this may reinforce the deep-sleep stage. They do not sedate you or help you fall asleep faster. The effect, if any, is about sleep quality and overnight recovery, not sleep onset.
Epithalon is studied mainly as a longevity peptide, with some human trial data in elderly cohorts reporting effects on circadian regulation and sleep. That data comes from a specific Russian research program that has not been widely replicated, so treat it cautiously. Sleep is a secondary finding here, not the primary reason most people look at this compound.
Hard to say, because they are studied for different things. Melatonin mainly signals sleep timing and can help with onset. The GH secretagogues here target deep-sleep quality through a different mechanism, and DSIP targets sleep induction with limited evidence. None of these peptides have been tested head-to-head against melatonin in large trials, so any comparison is speculative.
Educational information only. This is not medical advice. Peptide AI is an informational and tracking platform. Everything on this page is for general education. It is not a substitute for professional medical advice and is not a recommendation to use any compound. Many peptides listed here are research compounds the FDA has not approved for human use. Talk to a qualified, licensed healthcare provider before you start, change, or stop any protocol.
Peptide AI joins your doses, labs, and wearables so you can see which compounds actually move your numbers.